These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20529285)

  • 1. Biomarkers in acute myocardial infarction.
    Chan D; Ng LL
    BMC Med; 2010 Jun; 8():34. PubMed ID: 20529285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential clinical application of novel cardiac biomarkers for acute myocardial infarction.
    Nursalim A; Suryaatmadja M; Panggabean M
    Acta Med Indones; 2013 Jul; 45(3):240-50. PubMed ID: 24045397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers for cardiovascular risk prediction.
    Wang J; Tan GJ; Han LN; Bai YY; He M; Liu HB
    J Geriatr Cardiol; 2017 Feb; 14(2):135-150. PubMed ID: 28491088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
    Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin.
    Jacobs LH; van Borren M; Gemen E; van Eck M; van Son B; Glatz JF; Daniels M; Kusters R
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):550-61. PubMed ID: 25732130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
    Sabatine MS; Morrow DA; de Lemos JA; Gibson CM; Murphy SA; Rifai N; McCabe C; Antman EM; Cannon CP; Braunwald E
    Circulation; 2002 Apr; 105(15):1760-3. PubMed ID: 11956114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Biomarkers for Better Management of Acute Coronary Syndromes.
    Sathyamurthy I; Dalal JJ; Sawhney JP; Mohan JC; Chogle SA; Desai N; Sathe SP; Maisel AS
    J Assoc Physicians India; 2015 Jun; 63(6):46-50. PubMed ID: 26710400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
    Wiviott SD; Cannon CP; Morrow DA; Murphy SA; Gibson CM; McCabe CH; Sabatine MS; Rifai N; Giugliano RP; DiBattiste PM; Demopoulos LA; Antman EM; Braunwald E
    Circulation; 2004 Feb; 109(5):580-6. PubMed ID: 14769678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
    Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Bobadilla M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Korf-Klingebiel M; Kempf T; Lichtinghagen R; Katus HA; Giannitsis E; Wollert KC
    Clin Chem; 2013 Oct; 59(10):1497-505. PubMed ID: 23818444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction.
    Højagergaard MA; Hassager C; Christensen TE; Bang LE; Gøtze JP; Ostrowski SR; Holmvang L; Frydland M
    Biomarkers; 2020 Mar; 25(2):137-143. PubMed ID: 31902247
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study.
    Ricci F; Di Scala R; Massacesi C; Di Nicola M; Cremonese G; De Pace D; Rossi S; Griffo I; Cataldo I; Martinotti S; Rotondo D; Jaffe AS; Zimarino M; De Caterina R
    Am J Med; 2016 Jan; 129(1):105-14. PubMed ID: 26169889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era.
    Onda T; Inoue K; Suwa S; Nishizaki Y; Kasai T; Kimura Y; Fukuda K; Okai I; Fujiwara Y; Matsuoka J; Sumiyoshi M; Daida H
    Int J Cardiol; 2016 Sep; 219():180-5. PubMed ID: 27327504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation.
    Sanchis J; Bosch X; Bodí V; Bellera N; Núñez J; Benito B; Ordóñez J; Consuegra L; Heras M; Llècer A
    Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natriuretic peptides and multimarker approach to risk stratification of patients with acute coronary syndromes].
    Matunović R; Stojanović A; Mijailović Z; Cosić Z
    Med Pregl; 2006; 59(5-6):248-52. PubMed ID: 17039908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.